1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

MesoTV: Chemotherapy + immunotherapy, another positive step in mesothelioma treatment

Drs. Anne Tsao of MD Anderson Cancer Center, Patrick Forde of Johns Hopkins, and James Stevenson of the Cleveland Clinic join Mary Hesdorffer to discuss a new clinical trial, Dream3r, a phase 3 study into the efficacy of combination chemotherapy with immunotherapy as first line treatment for mesothelioma.

Our sponsors

MesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made possible by our generous sponsors: Maune Raichle Hartley French & Mudd, LLC (MRHFM)Belluck & FoxBristol Myers SquibbNovocureMerckThe Gori Law FirmEarly Lucarelli Sweeney & Meisenkothen.

Also...

In Other News

We’ve moved!

Effective tomorrow, August 1, 2023, the Mesothelioma Applied Research Foundation has two new addresses! Donations mailing address: PO Box 24041New York, NY 10087-4041 Business street

Read More »

Share:

Facebook
Twitter
LinkedIn